THU0106 In Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate, does Body Mass Index Influence the Efficacy of Abatacept on Inflammation when Measured by Power Doppler Ultrasonography? Results from the Appraise Study

THU0106 In Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate, does Body Mass Index Influence the Efficacy of Abatacept on Inflammation when Measured by Power Doppler Ultrasonography? Results from the Appraise Study

BackgroundStudies have shown an influence of BMI on clinical outcomes in patients with RA treated by anti-TNF agents.1 The efficacy of abatacept does not seem to be impacted by weight; baseline weight was not identified as a predictive factor of efficacy (DAS28 [CRP]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.231-232
Hauptverfasser: D'Agostino, M.A., Le Bars, M., Taylor, M., Chou, B., Zhu, J., Ranganath, V.K.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundStudies have shown an influence of BMI on clinical outcomes in patients with RA treated by anti-TNF agents.1 The efficacy of abatacept does not seem to be impacted by weight; baseline weight was not identified as a predictive factor of efficacy (DAS28 [CRP]
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2015-eular.1727